Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TREND-IVT
NCT06548971Phase 3Recruiting
- Sponsor
- Capital Medical University
- Start
- Nov 2024
- Primary completion
- Dec 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of aspirin in ischemic stroke, sponsored by Capital Medical University. Started Nov 2024; status: recruiting.
02
Drugs
aspirin
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT06548971.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06548971.